PB1822: INHIBITION OF THE DNA DAMAGE RESPONSE: A POSSIBLE NEW ROUTE IN ACUTE MYELOBLASTIC LEUKEMIA TREATMENT

• Beatriz Lapa,
• Maria Inês Costa,
• Joana Jorge,
• Raquel Alves,
• Ana Bela Sarmento-Ribeiro,
• Ana Cristina Gonçalves

Affiliations

Beatriz Lapa

1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal

Maria Inês Costa

1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal

Joana Jorge

1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal

Raquel Alves

1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal

Ana Bela Sarmento-Ribeiro

1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal

Ana Cristina Gonçalves

1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal